<?xml version="1.0" encoding="UTF-8"?>
<p>Eligible patients are randomly assigned to the flurbiprofen axetil group or the no-NSAIDs group by a minimisation method using (1) institution, (2) clinical stage (IA1, 2/IA3, IB/IIA or more), and (3) sex because postoperative adjuvant chemotherapy varies according to stage, and the prognosis varies according to sex.
 <xref rid="R34" ref-type="bibr">34 35</xref> The randomisation ratio is 1:1. The results of the assignment will not be made known to the study subjects.
</p>
